Evidence map›Paper›PMID 31401963›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2019

Improving risk assessment of the emergence of novel influenza A viruses by incorporating environmental surveillance.

Kim M Pepin, Matthew W Hopken, Susan A Shriner, Erica Spackman, Zaid Abdo, Colin Parrish, Steven Riley, James O Lloyd-Smith, Antoinette J Piaggio

Abstract read
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Dynamic and integrative approaches to understanding pathogen spillover.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Article
  7. Percolation models of pathogen spillover.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kim M PepinNational Wildlife Research Center, USDA-APHIS, Fort Collins, CO 80521, USA.
Matthew W HopkenNational Wildlife Research Center, USDA-APHIS, Fort Collins, CO 80521, USA.
Susan A ShrinerNational Wildlife Research Center, USDA-APHIS, Fort Collins, CO 80521, USA.
Erica SpackmanExotic and Emerging Avian Viral Diseases Research, USDA-ARS, Athens, GA 30605, USA.
Zaid AbdoColorado State University, Fort Collins, CO 80523, USA.
Colin ParrishBaker Institute for Animal Health, Department of Microbiology and Immunology, Cornell University, Ithaca, NY 14853, USA.
Steven RileyMRC Centre for Global Infectious Disease Analysis, Imperial College, London, SW7 2AZ, UK.
James O Lloyd-SmithUCLA, Los Angeles, CA 90095, USA.
Antoinette J PiaggioNational Wildlife Research Center, USDA-APHIS, Fort Collins, CO 80521, USA.

Funding

Medical Research Council MR/J008761/1Medical Research Council MR/R015600/1Wellcome Trust 200861/Z/16/Z
6 · The paper itself

Abstract

Reassortment is an evolutionary mechanism by which influenza A viruses (IAV) generate genetic novelty. Reassortment is an important driver of host jumps and is widespread according to retrospective surveillance studies. However, predicting the epidemiological risk of reassortant emergence in novel hosts from surveillance data remains challenging. IAV strains persist and co-occur in the environment, promoting co-infection during environmental transmission. These conditions offer opportunity to understand reassortant emergence in reservoir and spillover hosts. Specifically, environmental RNA could provide rich information for understanding the evolutionary ecology of segmented viruses, and transform our ability to quantify epidemiological risk to spillover hosts. However, significant challenges with recovering and interpreting genomic RNA from the environment have impeded progress towards predicting reassortant emergence from environmental surveillance data. We discuss how the fields of genomics, experimental ecology and epidemiological modelling are well positioned to address these challenges. Coupling quantitative disease models and natural transmission studies with new molecular technologies, such as deep-mutational scanning and single-virus sequencing of environmental samples, should dramatically improve our understanding of viral co-occurrence and reassortment. We define observable risk metrics for emerging molecular technologies and propose a conceptual research framework for improving accuracy and efficiency of risk prediction. This article is part of the theme issue 'Dynamic and integrative approaches to understanding pathogen spillover'.

Indexed as

AnimalsAnimals, WildEpidemiological MonitoringHumansInfluenza A virusInfluenza, HumanOrthomyxoviridae InfectionsRisk Assessmentco-infectionenvironmental transmissioninfluenza Areassortmentsingle-virus sequencingsurveillance

Identifiers

PMID31401963
PMCPMC6711309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.